Literature DB >> 16374045

Confirmation of the adult-onset primary open angle glaucoma locus GLC1B at 2cen-q13 in an Australian family.

Jac C Charlesworth1, James M Stankovich, David A Mackey, Jamie E Craig, Michael Haybittel, Rodney N Westmore, Michèle M Sale.   

Abstract

Primary open-angle glaucoma (POAG) is genetically heterogeneous, with 6 named POAG loci GLC1A-F mapped and genes myocilin (MYOC) and optineurin (OPTN) identified at 2 of the loci. Using penetrance-model-free methods, we screened the POAG loci GLC1A-F in an extended Australian pedigree, using 3-5 markers within each locus. p values of less than 0.05 were obtained empirically using SimWalk2 and exactly using Genehunter for 2 markers within the GLC1B region on chromosome 2. Fine mapping of this region produced p values of 0.01 or less at 5 markers flanked by D2S1897 and D2S2269. The 9 cM haplotype of interest overlaps the original GLC1B region. These results provide supportive evidence for the GLC1B locus on chromosome 2cen-q13 and verify the existence of POAG susceptibility gene in this region, increasing the likelihood of gene identification. 2006 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16374045     DOI: 10.1159/000089271

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  3 in total

1.  Identification of novel genetic loci for intraocular pressure: a genomewide scan of the Beaver Dam Eye Study.

Authors:  Priya Duggal; Alison P Klein; Kristine E Lee; Ronald Klein; Barbara E K Klein; Joan E Bailey-Wilson
Journal:  Arch Ophthalmol       Date:  2007-01

Review 2.  Major review: Molecular genetics of primary open-angle glaucoma.

Authors:  Yutao Liu; R Rand Allingham
Journal:  Exp Eye Res       Date:  2017-05-10       Impact factor: 3.467

3.  Association of HK2 and NCK2 with normal-tension glaucoma in a population from the Republic of Korea.

Authors:  Seung-Hyun Jung; Young Chun Lee; Mee Yon Lee; Hye-Young Shin
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-09-11       Impact factor: 3.117

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.